Citeline to Share Exclusive Insights from 42nd Annual J.P. Morgan Healthcare Conference
08 janv. 2024 09h00 HE
|
Citeline
Citeline, a Norstella company, will provide exclusive access, including daily insights, to the 42nd Annual J.P. Morgan Healthcare Conference Jan. 8-11.
SCRIP Award to Mesoblast Recognizes Strategic Importance of '2013 Financing Deal of the Year'
22 nov. 2013 06h00 HE
|
Mesoblast
NEW YORK and MELBOURNE, Australia, Nov. 22, 2013 (GLOBE NEWSWIRE) -- Regenerative medicine company Mesoblast Limited (ASX: MSB; OTC ADR: MBLTY) announced that it was today awarded the 'Financing Deal...